Real-world patients with acute myocardial infarction in Italian CCUs are older than trial populations and show divergent short-term mortality trends for STEMI and NSTEMI compared to expectations.
No takes yet. Share an insight, caveat, or question.
Real-world AMI mortality diverges from trials in older CCU patients; leaves open updated risk models for contemporary STEMI/NSTEMI.
Antonio Di Chiara (2003) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: